Related Experiment Video
Updated: Jun 16, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Combatting Fungal Infections: Advances in Antifungal Polymeric Nanomaterials
Sebastian Schaefer1,2,3,4, Nathaniel Corrigan1,2, Sascha Brunke4
1School of Chemical Engineering, University of New South Wales (UNSW), Sydney, New South Wales 2052, Australia.
Abstract:
Fungal pathogens cause over 6.5 million life-threatening systemic infections annually, with mortality rates ranging from 20 to 95%, even with medical intervention. The World Health Organization has recently emphasized the urgent need for new antifungal drugs. However, the range of effective antifungal agents remains limited and resistance is increasing. This Review explores the current landscape of fungal infections and antifungal drugs, focusing on synthetic polymeric nanomaterials like nanoparticles that enhance the physicochemical properties of existing drugs. Additionally, we examine intrinsically antifungal polymers that mimic naturally occurring peptides. Advances in polymer characterization and synthesis now allow precise design and screening for antifungal activity, biocompatibility, and drug interactions. These antifungal polymers represent a promising new class of drugs for combating fungal infections.
Insights
New polymeric nanomaterials offer hope against life-threatening fungal infections. These advanced materials, including nanoparticles and intrinsically antifungal polymers, show promise in overcoming drug resistance and improving treatment outcomes.
Area of Science:
- Medical Mycology
- Polymer Science
- Nanotechnology
Background:
- Fungal infections cause millions of severe illnesses annually with high mortality rates.
- Existing antifungal drugs face limitations due to increasing resistance and narrow efficacy.
- The World Health Organization highlights the critical need for novel antifungal therapies.
Purpose of the Study:
- To review the current state of fungal infections and antifungal drug development.
- To explore the potential of synthetic polymeric nanomaterials in antifungal therapy.
- To examine intrinsically antifungal polymers as a new class of therapeutic agents.
Main Methods:
- Review of current literature on fungal infections and antifungal agents.
- Focus on synthetic polymeric nanomaterials (e.g., nanoparticles) for drug delivery.
- Investigation of intrinsically antifungal polymers mimicking natural peptides.
Main Results:
- Polymeric nanomaterials can enhance the properties of existing antifungal drugs.
- Intrinsically antifungal polymers demonstrate potential as novel therapeutic agents.
- Advances in polymer science enable precise design and screening for antifungal applications.
Conclusions:
- Synthetic polymeric nanomaterials and intrinsically antifungal polymers represent a promising frontier in combating fungal infections.
- These novel materials offer potential solutions to overcome antifungal drug resistance.
- Further research and development in polymer-based antifungal agents are warranted.
Related Concept Videos
Candidiasis
Microbial Corrosion
Antifungal Agents
Site-Targeted Drug Delivery Systems: Polymeric Carriers

